Table 1.
N=14 | ||
---|---|---|
Parameter | No (Percent) | Median (Range) |
Diagnosis | ||
MDS | 13 (93) | |
CMML | 1(7) | |
Age (years) | 74.5 (58-85) | |
No. Azacitidine courses | 4 (1-10) | |
IPSS Risk Score | 2 (0.5-3) | |
Bone marrow blasts ≥10% | 12 (86) | |
2 or more cytopenias | 10 (72) | |
Cytogenetics: IPSS Risk category | ||
Low | 8 (57) | |
Intermediate | 2 (14) | |
High | 4 (29) | |
Reason off Azacitidine | ||
No response | 7 (59) | |
Progression | 4 (29) | |
Relapse | 2 (14) | |
Toxicity | 1 (7) |
Abbreviations: MDS= myelodysplastic syndrome, CMML= chronic myelomonocytic leukemia, IPSS= international prognostic scoring system